Panacea brings seasoned clinical research professionals with specialist expertise to each of its assignments. We have multi-therapeutic experience in domestic and international Phase I-IV pharmaceutical studies, as well as pilot, pivotal and post market medical device studies. No matter the size, scope or duration of the study, we are successful at organizing and implementing a complete clinical trial process to accelerate the development and submission of your medical product.

Lawrence W. Yarmaloff, CCRA, President & Principal Consultant
Mr. Yarmaloff is the President and Principal Consultant at Panacea Clinical Research www.panaceaclinical.com, a clinical research consulting firm located in the Boston area.  Panacea Clinical Research provides GCP quality assurance, monitoring, and project management services to pharmaceutical and medical device sponsor companies worldwide.  
 
Mr. Yarmaloff has over 20 years of experience in the clinical research industry.  He started his clinical research career by coordinating clinical trials and research laboratory testing for the Department of Histocompatability and Immunogenetics at Brigham and Women’s Hospital in Boston.  In 1991, Mr. Yarmaloff joined Quintiles, Inc. as a Clinical Research Associate. Following his tenure at Quintiles, he served in clinical monitoring, project management and quality assurance roles at ImmunoGen, Inc. and Paragon Biomedical, Inc. from 1993-2000.  
 
In 2000, Mr. Yarmaloff founded Panacea Clinical Research.  As Principal, he provides consulting services including clinical program management, compliance auditing, FDA/BIMO inspection preparation, and development of GCP quality risk management solutions.    
 
Mr. Yarmaloff holds a Bachelor’s Degree in Chemistry from Bates College, and is accredited by the Associates of Clinical Research Professionals (ACRP) as a Certified Clinical Research Associate (CCRA). He is an active member of ACRP and of the Society of Quality Assurance (SQA).